Candriam Equities L Oncology, N - Capitalisation
WKN A3D92J | ISIN LU2346866317 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | IE000G3N3NE7 | Janus Henderson Global Life Sciences Fund G2 EUR | +35,10 % | +15,52 % | 2,09 |
|
| 2 | LU2346866317 | Candriam Equities L Oncology, N - Capitalisation | +36,38 % | +16,41 % | 2,06 |
|
| 3 | IE00BRJG6X20 | Janus Henderson Global Life Sciences Fund I2 EUR | +33,98 % | +15,48 % | 2,03 |
|
| 4 | IE000A563JT7 | Jupiter Systematic Healthcare Innovation Fund, F EUR Acc | +29,23 % | +13,18 % | 2,02 |
|
| 5 | LU2387456671 | Franklin Genomic Advancements Fund - I (acc) EUR | +44,54 % | +21,82 % | 1,92 |
|
| 338 | LU0580275534 | Bellevue Funds (Lux) - Bellevue Medtech & Services HB EUR - Accumulating | -14,51 % | +16,46 % | -1,04 |
|
| 339 | LU0969575645 | Variopartner SICAV - MIV Global Medtech Fund I3 USD | -16,28 % | +17,30 % | -1,09 |
|
| 340 | LU1050446076 | Variopartner SICAV - MIV Global Medtech Fund N3 USD | -16,45 % | +17,30 % | -1,10 |
|
| 341 | LU0969575561 | Variopartner SICAV - MIV Global Medtech Fund P3 USD | -16,78 % | +17,30 % | -1,12 |
|
| 342 | LU0580237955 | Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating | -16,04 % | +16,45 % | -1,13 |
|